According to experts at Clearsky recovery: “Ibogaine is a naturally occurring psychoactive indole alkaloid derived from the roots of the African rain forest shrub Tabernanthe iboga”. They go on to explain that: “Ibogaine belongs to the Apocynaceae family and that it is traditionally used by the Bwiti, indigenous peoples of Western Africa.
The key is to consume it in low doses in order to combat fatigue, hunger and thirst”. It is also claimed that higher doses of ibogaine is part of spiritual initiation ceremonies.
The Urgency For Ibogaine Research Is Prompted By An Opioid Crisis
In the western world, we have a more pressing problem: Opioid addiction. Recently, in 2016 the CDC attributed 64 000 deaths to drug overdose, an annual increase* of 17.7%. Many of our people travelled abroad not for spiritual ceremonies or traditional studies, but literally to save their own lives as they suffered from drug addiction.
As the trend of drug addiction accelerates, so do we see more people opting for ibogaine treatment (Keep it as do follow)hence the topic now is worthy of our attention. Despite criticism to how the US administration is dealing with the crisis, in fairness to President Trump – he went as far as to donate part of his salary towards an awareness campaign.
Is The West Behind In Research?
One has to recognize that our western medical and pharmaceutical institutions are not always ahead with research, particularly where substances are prohibited. In the US, for example, ibogaine is illegal – which means that clinical trials cannot be carried out. To date there was only one establishment in the US who were allowed to carry out research with drug dependent patients.
As such, many US researchers traveled to Mexico and Canada to interview patients at biomedical research facilities. As far as mainstream medicine is concerned, the official line in the US is this: “ibogaine is illegal and it can kill you”.
Indeed alcohol, cigarettes and air pollution can also kill you hence it is regrettable that at this point in time, US participation into ibogaine has been so limited which is indeed ironic. After all we urgently require a solution to the current opioid epidemic.
Yes, the president did declare a war on opioids and even donated a part of his salary to raise awareness. Yet this was done without initiating FDA and healthcare system reforms that will solve the issue at it’s root.
Some would claim that since ibogaine is anti-addictive, it is in fact not commercially viable and that big pharma stand to gain more by marketing drugs that is addictive – we would not go as far as to publicly agree with this notion although it is an interesting train of thought.
Clear Sky Recovery is a world leader in ibogaine treatment it’s founders were the only people ever to have been granted permission to carry out trials in the US. Their rehab facility is based in Mexico where Dr. Alberto Solar is the Medical Director.
Ibogaine Research Dates Back To The Early 1900’s
Worldwide efforts on ibogaine research can be traced back as far as 1901, when French nationals Dybowsky and Landri embarked upon this journey. Already in 1930, “Lambarene” was marketed in France as a pharmaceutical medication, which was in fact Ibogaine.
At the time is was used widely for depression, asthenia and convalescence but was withdrew from the market some 30 years later. Well at one point, even the US played a role: in 1985 and 1986 Howard Lats of was granted relevant patents. In 1985 it was the “Rapid method for interrupting the narcotic addiction syndrome (USPTO #: 4,499,096)”.
Then in 1986 a further patent was “Ibogaine vs. stimulants (cocaine and amphetamine. USPTO #: 4,587,243”. Eventually in 1995 the US suspended further research – and even now with the current opioid epidemic, it was not reinstated.
Around this time, 1994 to 1995, hospitals in Panama experimented with Ibogaine treatment, followed by a more extensive research project in St. Kitts (West Indies) which lasted from 1996 to 2003.
As a result of research, evidence began to surface in peer reviewed journals more recently. This ultimately led to experts at Clearsky recovery saying “We can unequivocally state that ibogaine has anti-addictive properties”. In a panel interview with Entheo Science, Patrick Kroupa, a consultant at Clear Sky Recovery stated: “Almost everybody I treated had their lives improve*”.
He noted that “the people who did the best long-term, were those who fill out the huge black hole that used to be occupied by drugs”. It can be inferred from his contribution at the panel that positive long-term outcomes were mainly achieved by those who made an effort to fill the void caused by drugs, as opposed to treating Ibogaine as a magic* bullet. Indeed it is merely the most important starting point on the road back to complete recovery.
Looking At The Future Of Ibogaine Research
It may yet again not involve the US, perhaps due to the approach of the current US administration which simply declared war on all illegal substances and wishes to solve the problem by building a wall.
But what about drugs being sold on prescription inside the country? Fortunately countries like Mexico, Canada and Spain – as well as a string of smaller countries are continuing their efforts with research. The success stories of those who come forward after ibogaine treatment can no longer be kept silent.
What we need in the world is to make greater strides against drug addiction and to fight back through socially intelligent strategies that are up to date. This is no doubt an area that will be closely watched by stakeholders from around the world.
Feature Image: Shutterstock.com
In-Post Image: Shutterstock.com & clearskyibogaine.com
This is a sponsored post written by Adriaan Brits. The opinions expressed in this article are the sponsor’s own. Learn more about contributing for Consumer Health Digest.